References
- Crichton, R. R. (1996). Iron homeostasis: from microbes to man, European Chemistry Chronicle, 1, 11–17.
- Paolicchi, A., Minotti, G., Tonarelli, P., Tongiani, R., De Cesare, D., Mezzetti, A., et al. (1999). γ-glutamyl transpeptidase-dependent iron reduction and LDL oxidation—a potential mechanism in atherosclerosis, J Investig Med, 47, 151–160.
- Frewin, R. J. and Smith, A. G. (1996). The diagnosis and treatment of iron deficiency, Hematology, 1, 259–266.
- Ashby, D. (1996). Can iron supplementation improve cognitive functioning? Lancet, 348, 973.
- Edgerton, V. R., Gardner, G. W., Ohira, Y., Gunawardena, K. A. and Senewiratne, B. (1979). Iron-deficiency anaemia and its effect on worker productivity and activity patterns, Br Med J, 2, 1546–1549.
- Basta, S. S., Soekirman, M. S., Karyadi, D. and Scrimshaw, N. S. (1979). Iron deficiency anemia and the productivity of adult males in Indonesia, Am J Clin Nutr, 32, 916–925.
- Beinert, H. and Kennedy, M. C. (1993). Aconitase, a twofaced protein: enzyme and iron regulatory factor, FASEB J, 7, 1442–1449.
- Caraceni, P., Fagiuoli, S. and Van Thiel, D. H. (1994). Iron reduction therapy: simply camouflage, or a real weapon? Am J Gastroenterol, 89, 970–973.
- Sempos, C. T., Looker, A. C., Gillum, R. F. and Makuc, D. M. (1994). Body iron stores and the risk of coronary heart disease, N Engl J Med, 330, 1119–1124.
- Ascherio, A. and Willett, W. C. (1994). Are body iron stores related to the risk of coronary heart disease? N Engl J Med, 330, 1152–1154.
- Beare, S. and Steward, W. P. (1996). Plasma free iron and chemotherapy toxicity, Lancet, 347, 342–343.
- McCord, J. M. (1998). Iron, free radicals, and oxidative injury, Semin Hematol, 35, 5–12.
- Herbert, V., Shaw, S., Jayatilleke, E. and Stopler-Kasdan, T. (1994). Most free-radical injury is iron-related: it is promoted by iron, hemin, holoferritin and vitamin C, and inhibited by desferoxamine and apoferritin, Stem Cells, 12, 289–303.
- Jacobs, P., Fransman, D. and Coghlan, P. (1993). Comparative bioavailability of ferric polymaltose and ferrous sulphate in iron-deficient blood donors, J Clin Apheresis, 8, 89–95.
- Tuomainen, T. P., Nyyssönen, K., Porkkala-Sarataho, E., Salonen, R., Baumgartner, J. A., Geisser, P. and Salonen, J. T. Oral supplementation with ferrous sulfate but not with non-ionic iron polymaltose complex increases the susceptibility of plasma lipoproteins to oxidation. [In press]
- Jacobs, P., Johnson, G. and Wood, L. (1985). Oral iron therapy in human subjects, comparative absorption between ferrous salts and iron polymaltose, J Med, 15, 367–377.
- Umbreit, J. N., Conrad, M. E., Moore, E. G. and Latour, L. F. (1998). Iron absorption and cellular transport: the mobilferrin/paraferritin paradigm, Semin Hematol, 35, 13–26.
- Macfarlane, B. J. (1989). Factors affecting iron absorption from a variety of food substances. Johannesburg: Univ. of the Witwatersrand; [Dissertation].
- Johnson, G. and Jacobs, P. (1990). Bioavailability and the mechanisms of intestinal absorption of iron from ferrous ascorbate and ferric polymaltose in experimental animals, Exp Hematol, 18, 1064–1069.
- Jacobs, P. (1987). Equivalent bioavailability of iron from ferrous salts and a ferric polymaltose complex: clinical and experimental studies, Arzneimittelforschung, 37, 113–116.
- Jacobs, P. and Wormald, L. (1979). The bioavailability of an iron polymaltose complex for treatment of iron deficiency, J Med, 10, 279–285.
- Jacobs, P., Wormald, L. A. and Gregory, M. C. (1979). Absorption of iron polymaltose and ferrous sulphate in rats and humans: a comparative study, S Afr Med J, 55, 1065–1072.
- Morse, E. E., Cable, R., Pisciotto, P., Kakaiya, R. and Kiraly, T. (1987). Evaluation of iron status in women identified by copper sulfate screening as ineligible to donate blood, Transfusion, 27, 238–241.
- Revised recommendations for the measurements of the serum iron in human blood. Iron Panel of the International Committee for Standardization in Haematology, Br J Haematol, (1990), 75, 615–616.
- The measurement of total and unsaturated iron-binding capacity in serum. International Committee for Standardization in Haematology, Br J Haematol, (1978), 38, 281–290.
- Alfrey, C. P. (1978). Serum ferritin assay, CRC Crit Rev Clin Lab Sci, 9, 179–208.
- Storring, P. L. and Gaines Das, R. E. (1992). The international standard for recombinant DNA-derived erythropoietin: collaborative study of four recombinant DNA-derived erythropoietins and two highly purified human urinary erythropoietins, J Endocrinol, 134, 459–484.
- Bezwoda, W. R., Bothwell, T. H., Torrance, J. D., MacPhail, A. P., Charlton, R. W., Kay, G. and Levin, J. (1979). The relationship between marrow iron stores, plasma ferritin concentrations and iron absorption, Scand J Haematol, 22, 113–120.
- Jacobs, P., Wood, L., Marshall, J. A., Bird, A. R. and Geisser, P. (1998). Ferric polymaltose complexes are equally bioavailable to ferrous sulphate in the treatment of iron deficiency anaemia in regular blood donors. ISH-EHA, Combined Haematology Congress, 4–8 July 1998, Amsterdam, Br J Haematol, 102, 219.
- Finch, C. (1994). Regulators of iron balance in humans, Blood, 84, 1697–1702.
- Sayers, M. H., English, G. and Finch, C. (1994). Capacity of the store-regulator in maintaining iron balance, Am J Hematol, 47, 194–197.
- Ponka, P., Beaumont, C. and Richardson, D. R. (1998). Function and regulation of transferrin and ferritin, Semin Hematol, 35, 35–54.
- Melefors, Ö. and Hentze, M. W. (1993). Iron regulatory factor—the conductor of cellular iron regulation, Blood Rev, 7, 251–258.
- Moyo, V. M., Gangaidzo, I. T., Gomo, Z. A. R., Khumalo, H., Saungweme, T., Kiire, C. F., et al. (1997). Traditional beer consumption and the iron status of spouse pairs from a rural community in Zimbabwe, Blood, 89, 2159–2166.